Your session is about to expire
← Back to Search
Behavioral Therapy for Early Psychosis
N/A
Recruiting
Led By Stephanie Rolin, MD, MPH
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will test a therapy to help people with early psychosis reduce their violent behavior.
Who is the study for?
This trial is for young adults aged 16 to 30 who are receiving treatment for early psychosis at OnTrackNY clinics and can participate in research interviews. They must have a diagnosis within the schizophrenia spectrum, excluding affective psychoses, and be fluent in English.Check my eligibility
What is being tested?
The study tests an adapted behavioral intervention designed to reduce violent behavior in individuals with early-stage nonaffective psychotic disorders such as schizophrenia.See study design
What are the potential side effects?
Since this is a behavioral intervention rather than a medication, traditional side effects are not expected. However, participants may experience emotional or psychological discomfort during therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean Acceptability of Intervention Measure (AIM)
Mean Feasibility of Intervention Measure (FIM)
Number of EIS Participants in Attendance
Trial Design
1Treatment groups
Experimental Treatment
Group I: behavioral interventionExperimental Treatment1 Intervention
This will involve conducting a 12-week open pilot trial (up to n=16 dyads of EIS clinicians-EIS participants) to test the feasibility and acceptability of the adapted Psychological Interventions for Coping with Anger and Schizophrenia: a study of outcomes (PICASSO) intervention in the OnTrackNY setting.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,436 Previous Clinical Trials
2,448,264 Total Patients Enrolled
24 Trials studying Schizophrenia
3,418 Patients Enrolled for Schizophrenia
National Institute of Mental Health (NIMH)NIH
2,794 Previous Clinical Trials
2,693,833 Total Patients Enrolled
250 Trials studying Schizophrenia
89,421 Patients Enrolled for Schizophrenia
Stephanie Rolin, MD, MPHPrincipal InvestigatorColumbia University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am aged 16-30 and have been diagnosed with a type of nonaffective psychosis.I am not fluent in English.I am willing to do interviews after each study visit.I am unable to understand and give consent for treatment.I am receiving treatment for my first episode of psychosis at an OnTrackNY clinic.
Research Study Groups:
This trial has the following groups:- Group 1: behavioral intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the age range for trial participation extend beyond 40 years?
"The target demographic of this clinical trial is individuals aged between 16 and 30."
Answered by AI
Could you explain what type of individuals would be most ideal for this clinical trial?
"In order to be eligible for this trial, individuals must have a diagnosis of schizophrenia and fit within the designated age range (16-30). Currently, 16 patients are being recruited."
Answered by AI
Are there any openings to participate in the experiment?
"The details on clinicaltrials.gov demonstrate that this specific trial, which was first registered on April 1st 2023 and modified most recently on February 23rd, is no longer recruiting patients. However, 1453 other trials are seeking participants at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger